🔎 Trials Near Me

Home › Myeloproliferative Neoplasms › Alabama › Birmingham

Myeloproliferative Neoplasms clinical trials in Birmingham, AL

8 studies for Myeloproliferative Neoplasms are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RecruitingPhase 2
  • University of Alabama at Birmingham Cancer Center, Birmingham
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05564390

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RecruitingPhase 2
  • University of Alabama at Birmingham Cancer Center, Birmingham
Ages 18 to 59 · All sexes · Updated Sep 22, 2026 · NCT05554406

Project: Every Child for Younger Patients With Cancer

RecruitingObservational study
  • Children's Hospital of Alabama, Birmingham
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

RecruitingPhase 1
  • University of Alabama At Birmingham, Birmingham
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT07441694

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Birmingham
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant

RecruitingPhase 2
  • University of Alabama at Birmingham, Birmingham
Ages 18 to 75 · All sexes · Updated Oct 8, 2025 · NCT06265584

Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant

RecruitingPhase 2
  • University of Alabama at Birmingham, Birmingham
Ages 18 to 60 · All sexes · Updated Oct 8, 2025 · NCT06315309

Myeloproliferative Neoplasms trials in other cities

Other studies in Birmingham

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.